Skip to main content

Table 2 Subgroup analysis of ESBL-producing Escherichia coli and Klebsiella pneumoniae in animals

From: “One Health” perspective on prevalence of co-existing extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: a comprehensive systematic review and meta-analysis

Risk factors

Number of studies

Pooled estimates

Measure of heterogeneity

Publication bias

Sample

size

ESBL positive

I2 (95%CI)

Q Value

I2

Q

Beg and Mazumdar rank

P-value

 

Overall Animal

         

E. coli

17

3282

872

33.5% (13.1–36.1)

606.921

97.364

< 0.001

0.65046

 

 K. pneumoniae

16

2753

324

19.4% (9.7–34.9)

307.376

95.120

< 0.001

0.47130

 

Study year

         

2011–2020

         

E. coli

11

664

346

75% (41.5–62.1)

357.913

97.206

< 0.001

0.31151

 

 K. pneumoniae

10

398

90

17.1% (6.5–37.9)

210.352

95.721

< 0.001

0.42083

 

2021–2022

         

E. coli

6

2618

526

61.8% (25.5–88.4)

234.455

97.867

< 0.001

0.57303

 

 K. pneumoniae

6

2355

144

23.7% (7.6–53.9)

95.062

94.740

< 0.001

0.57303

 

Samples

         

Chickens

         

E. coli

5

578

287

48.0% (14.0–80.0)

209.184

98.088

< 0.001

0.14164

 

K. pneumoniae

5

288

82

43.5% (15.0–77.0)

68.954

94.199

< 0.001

0.5000

 

Countries

         

Nigeria

         

E. coli

3

442

169

33.4% (3.5–87.2)

166.522

98.799

< 0.001

0.11719

 

 K. pneumoniae

3

248

28

11.9% (8.0–17.5)

2

18.847

< 0.001

0.11719

 

Continent

         

Africa

         

E. coli

9

1085

555

49.6% (28.2–71.1)

282.725

97.171

< 0.001

0.40425

 

K. pneumoniae

9

734

166

32.9% (16.6–56.6)

139.268

94.256

< 0.001

0.40425

 

Asia

         

E. coli

5

341

159

44.5% (24.5–66.5)

47.327

91.548

< 0.001

1.0000

 

 K. pneumoniae

4

163

60

33.7% (14.7–60.1)

24.560

87.785

< 0.001

1.0000

 

Europe

         

E. coli

2

1407

62

 

K. pneumoniae

2

1407

5

 

North America

         

E. coli

1

449

96

 

K. pneumoniae

1

449

3